SVAAX
Price
$6.03
Change
-$0.02 (-0.33%)
Updated
May 22 closing price
Net Assets
8.17B
VIVAX
Price
$66.01
Change
-$0.28 (-0.42%)
Updated
May 22 closing price
Net Assets
183.65B
Interact to see
Advertisement

SVAAX vs VIVAX

Header iconSVAAX vs VIVAX Comparison
Open Charts SVAAX vs VIVAXBanner chart's image
Federated Hermes Strategic Value Div A
Price$6.03
Change-$0.02 (-0.33%)
VolumeN/A
Net Assets8.17B
Vanguard Value Index I
Price$66.01
Change-$0.28 (-0.42%)
VolumeN/A
Net Assets183.65B
SVAAX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SVAAX vs. VIVAX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVAAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. SVAAX (8.17B). SVAAX pays higher dividends than VIVAX: SVAAX (3.37) vs VIVAX (2.22). SVAAX was incepted earlier than VIVAX: SVAAX (20 years) vs VIVAX (33 years). SVAAX (1.17) is less costly to investors than VIVAX (0.17). SVAAX is a more actively managed with annual turnover of: 35.00 vs. VIVAX (9.00). SVAAX has a lower initial minimum investment than VIVAX: SVAAX (1500) vs VIVAX (3000). SVAAX annual gain was more profitable for investors over the last year : 10.69 vs. VIVAX (4.71). VIVAX return over 5 years is better than : 75.18 vs. SVAAX (61.81).
SVAAXVIVAXSVAAX / VIVAX
Total Expense Ratio1.060.17624%
Annual Report Gross Expense Ratio1.170.17688%
Fund Existence20 years33 years-
Gain YTD3.8930.3751,039%
Front Load6%N/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets8.17B184B4%
Annual Yield % from dividends3.372.22152%
Returns for 1 year10.694.71227%
Returns for 3 years7.7521.9735%
Returns for 5 years61.8175.1882%
Returns for 10 years33.8697.3535%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQH52.130.29
+0.56%
Equitable Holdings
TGNA16.74N/A
N/A
TEGNA
FLGT20.28N/A
N/A
Fulgent Genetics
OFS8.29-0.15
-1.78%
OFS Capital Corp
ENSC2.17-0.06
-2.91%
Ensysce Biosciences